Spinardi L, Einheber S, Cullen T, Milner T A, Giancotti F G
Department of Pathology, New York University School of Medicine, New York 10016, USA.
J Cell Biol. 1995 Apr;129(2):473-87. doi: 10.1083/jcb.129.2.473.
To examine the function of the alpha 6 beta 4 integrin we have determined its ligand-binding ability and overexpressed two potentially dominant negative mutant beta 4 subunits, lacking either the cytoplasmic or extracellular domain, in bladder epithelial 804G cells. The results of cell adhesion and radioligand-binding assays showed that alpha 6 beta 4 is a receptor for several laminin isoforms, including laminin 1, 2, 4, and 5. Overexpression of the tail-less or head-less mutant beta 4 subunit did not suppress alpha 6 beta 4-mediated adhesion to laminins, as both types of transfectants adhered to these ligands in the presence of blocking anti-beta 1 antibodies as well as the controls. However, immunofluorescence experiments indicated that the endogenous alpha 6 beta 4 integrin and other hemidesmosomal markers were not concentrated in hemidesmosomes in cells overexpressing tail-less beta 4, while the distribution of these molecules was not altered in cells overexpressing the head-less subunit. Electron microscopic studies confirmed that cells overexpressing tail-less beta 4 had a drastically reduced number of hemidesmosomes, while cells expressing the head-less subunit had a normal number of these structures. Thus, expression of a tail-less, but not a head-less mutant beta 4 subunit leads to a dominant negative effect on hemidesmosome assembly without suppressing initial adhesion to laminins. We conclude that the alpha 6 beta 4 integrin binds to several laminins and plays an essential role in the assembly and/or stability of hemidesmosomes, that alpha 6 beta 4-mediated adhesion and hemidesmosome assembly have distinct requirements, and that it is possible to use a dominant negative approach to selectively interfere with a specific function of an integrin.
为了研究α6β4整合素的功能,我们测定了其配体结合能力,并在膀胱上皮804G细胞中过表达了两种潜在的显性负性突变β4亚基,它们分别缺失胞质结构域或胞外结构域。细胞黏附试验和放射性配体结合试验结果表明,α6β4是几种层粘连蛋白异构体的受体,包括层粘连蛋白1、2、4和5。无尾或无头突变β4亚基的过表达并未抑制α6β4介导的对层粘连蛋白的黏附,因为在存在阻断性抗β1抗体的情况下,这两种转染细胞均能黏附这些配体,对照组也是如此。然而,免疫荧光实验表明,在过表达无尾β4的细胞中,内源性α6β4整合素和其他半桥粒标记物并未集中在半桥粒中,而过表达无头亚基的细胞中这些分子的分布未发生改变。电子显微镜研究证实,过表达无尾β4的细胞中半桥粒数量大幅减少,而过表达无头亚基的细胞中这些结构数量正常。因此,无尾而非无头突变β4亚基的表达对半桥粒组装产生显性负性效应,而不抑制对层粘连蛋白的初始黏附。我们得出结论,α6β4整合素与几种层粘连蛋白结合,在半桥粒的组装和/或稳定性中起重要作用,α6β4介导的黏附和半桥粒组装有不同的要求,并且有可能使用显性负性方法选择性干扰整合素的特定功能。